Why Coursera, Inc. (NYSE:COUR) Could Be Worth Watching
Coursera 'Well-Positioned' in GenAI World Due to Global Client Base, Multi-Sided Business Model, RBC Says
RBC Capital Maintains Coursera(COUR.US) With Buy Rating, Maintains Target Price $18
Express News | Moderna And Coursera Disclosed A Partnership To Launch MRNAs As Medicines, A Three-module Course Designed By Experts At Moderna That Offers A Comprehensive Understanding Of MRNA Medicines
Moderna and Coursera Launch Free Course on MRNA Technology
DeepL, Incluida En La Lista Forbes Cloud 100 Por Segundo Año Consecutivo
Coursera Second Quarter 2024 Earnings: Beats Expectations
Coursera | 10-Q: Q2 2024 Earnings Report
Analysts Are Bullish on These Technology Stocks: Coursera (COUR), Judges Scientific (GB:JDG)
Coursera (COUR) Surprises the Market After the Smoke Clears
Why Coursera Stock Dived by Almost 13% Today
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Why Coursera (COUR) Shares Are Falling Today
What Coursera, Inc.'s (NYSE:COUR) 65% Share Price Gain Is Not Telling You
Is Now The Time To Look At Buying Coursera, Inc. (NYSE:COUR)?
A Quick Look at Today's Ratings for Coursera(COUR.US), With a Forecast Between $11 to $22
Small U.S. Stocks Move Upward; Coursera Leads Increases
These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
No Data